Scripta Therapeutics: Valuation, Funding & Investors
Scripta Therapeutics is an Oxford-based techbio company on a mission to deliver transformative therapeutics through cutting edge technology. By focusing on altering the activity of transcription factors – the master controllers of biology – Scripta is searching for drugs with the potential not just to delay disease progression, but to halt or even reverse it. Combining pharma, biotech, and disease biology expertise with the computational power to push the boundaries of biology, Scripta aims to deliver disease-modifying therapeutics that transform outcomes for patients.
Leadership & Board
- Current Number of Employees
- 22
- Current LinkedIn Followers
- 3,148
Latest Estimated Valuation
- Total Amount Raised
- $12M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $12M
- Latest Funding Round
- Seed Round
Employee Trend
Scripta Therapeutics had 22 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Scripta Therapeutics had 3,148 followers as of November 16, 2026. The number of followers increased by 37 (1.19%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 13, 2025 | Seed Round | $12.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Oxford Science Enterprises | Seed Round |
| Parkwalk Advisors | Seed Round |
| AlbionVC | Seed Round |
| Apollo Health Ventures | Seed Round |
| YZR Capital | Seed Round |
| Oxford University Innovation | Seed Round |
Similar Companies
A snapshot of private companies similar to Scripta Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis









